exactly - I've been texting the CEO John Strong, who is pretty titght-lipped, but he has been replying to some questions. He is also co-founder, with a man named Peter Adams, of a private company "Adams Pharma" (cannot locate on Google), which "owns 5 secondary use patents on 5 ace inhibitor, targeting an indication for prevnetion of arterosclerosis". I could not get hime to commit to telling me anymore information about whether Adams pharma will reverse merge into ADTM. So I asked him again if he could offer at least a timeline for when he would publish a PR shareholder update or a filing. says, "i cannot discuss at the moment".

That's it.